Psychiatria pre prax 4/2012

Pharmacotherapy of anxiety. Have we other possibilities than SSRI?

Anxiety disorders with lifetime prevalence 28.8 % belong among the most common illnesses. The short overview of pharmacotherapeutical possibilities other than SSRI´s (selective serotonine reuptake inhibitors) with respect to the fast onset and long-term efficacy (agomelatine, venlafaxine, duloxetine, pregabaline and some older antidepressants) are introduced in this article. Pharmaceuticals marketed in Czech republic with proved efficacy in double blind, placebo controlled studies of the most commen anxiety disorders (generalized anxiety disorder, social phobia and panic disorder) are mentioned in this summary.

Keywords: generalized anxiety disorder, panic disorder, social phobia, pharmacotherapy, antidepressants, anxiolytics.